Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Britta Schumacher

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Farmaco (Societa Chimica Italiana : 1989)|May 28, 2003
Pyrimidin-8-on[2,1-f]theophylline-9-alkylcarboxylic acids amides as A1 and A2A adenosine receptor ligandsOmeran Fhid, Maciej Pawlowski, Slawomir Jurczyk, et al.
Life Sciences|August 15, 2002
Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptorsChrista E Müller, Britta Schumacher, Axel Brattström, et al.
Journal of Natural Products|October 26, 2002
Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptorsBritta Schumacher, Silke Scholle, Josef Hölzl, et al.
Maternal & Child Nutrition|September 14, 2023
A conceptual framework of urban food security and nutrition in low- and middle-income country settings applied to the Asia-Pacific regionPaula Griffiths, Emily Rousham, Sophie Goudet, et al.
European Journal of Medicinal Chemistry|March 31, 2004
Imidazo[2,1-b]thiazepines: synthesis, structure and evaluation of benzodiazepine receptor bindingKatarzyna Kieć-Kononowicz, Janina Karolak-Wojciechowska, Barbara Michalak, et al.
Chemmedchem|August 12, 2006
Improving potency, selectivity, and water solubility of adenosine A1 receptor antagonists: xanthines modified at position 3 and related pyrimido[1,2,3-cd]purinedionesStefanie Weyler, Friederike Fülle, Martina Diekmann, et al.
Bioorganic & Medicinal Chemistry|January 9, 2003
2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptorsVita Ozola, Mark Thorand, Martina Diekmann, et al.
Bioorganic & Medicinal Chemistry|May 15, 2007
N9-benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: synthesis and structure-activity relationships at adenosine A1 and A2A receptorsAnna Drabczyńska, Christa E Müller, Janina Karolak-Wojciechowska, et al.
European Journal of Medicinal Chemistry|May 17, 2003
Impact of the aryl substituent kind and distance from pyrimido[2,1-f]purindiones on the adenosine receptor selectivity and antagonistic propertiesAnna Drabczyńska, Britta Schumacher, Christa E Müller, et al.
Bioorganic & Medicinal Chemistry|September 1, 2004
Tricyclic oxazolo[2,3-f]purinediones: potency as adenosine receptor ligands and anticonvulsantsAnna Drabczyńska, Christa E Müller, Britta Schumacher, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Farmaco (Societa Chimica Italiana : 1989)|May 28, 2003
Pyrimidin-8-on[2,1-f]theophylline-9-alkylcarboxylic acids amides as A1 and A2A adenosine receptor ligandsOmeran Fhid, Maciej Pawlowski, Slawomir Jurczyk, et al.
Life Sciences|August 15, 2002
Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptorsChrista E Müller, Britta Schumacher, Axel Brattström, et al.
Journal of Natural Products|October 26, 2002
Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptorsBritta Schumacher, Silke Scholle, Josef Hölzl, et al.
Maternal & Child Nutrition|September 14, 2023
A conceptual framework of urban food security and nutrition in low- and middle-income country settings applied to the Asia-Pacific regionPaula Griffiths, Emily Rousham, Sophie Goudet, et al.
European Journal of Medicinal Chemistry|March 31, 2004
Imidazo[2,1-b]thiazepines: synthesis, structure and evaluation of benzodiazepine receptor bindingKatarzyna Kieć-Kononowicz, Janina Karolak-Wojciechowska, Barbara Michalak, et al.
Chemmedchem|August 12, 2006
Improving potency, selectivity, and water solubility of adenosine A1 receptor antagonists: xanthines modified at position 3 and related pyrimido[1,2,3-cd]purinedionesStefanie Weyler, Friederike Fülle, Martina Diekmann, et al.
Bioorganic & Medicinal Chemistry|January 9, 2003
2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptorsVita Ozola, Mark Thorand, Martina Diekmann, et al.
Bioorganic & Medicinal Chemistry|May 15, 2007
N9-benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: synthesis and structure-activity relationships at adenosine A1 and A2A receptorsAnna Drabczyńska, Christa E Müller, Janina Karolak-Wojciechowska, et al.
European Journal of Medicinal Chemistry|May 17, 2003
Impact of the aryl substituent kind and distance from pyrimido[2,1-f]purindiones on the adenosine receptor selectivity and antagonistic propertiesAnna Drabczyńska, Britta Schumacher, Christa E Müller, et al.
Bioorganic & Medicinal Chemistry|September 1, 2004
Tricyclic oxazolo[2,3-f]purinediones: potency as adenosine receptor ligands and anticonvulsantsAnna Drabczyńska, Christa E Müller, Britta Schumacher, et al.
Pageof 2